TSXV:SQD.H - Post Discussion
Post by
FactFinder1994 on Apr 11, 2023 11:17am
Traferox Technologies Inc...another part of the ecosystem
Over the last couple decades Shaf has acted on his vision and created an ecosystem that SQI has become an important part of. While this remains a relatively unknown fact, it is very much the case.
In order to perform personalized medicine, it is necessary to have top notch multiplex diagnostics, and especially when they can be performed at point of need in only minutes.
Prof. Keshavjee is a founder, shareholder, and Chief Medical Officer of Traferox Technologies Inc. and a consultant for Lung Bioengineering.
Prof. Cypel is a founder and shareholder of Traferox Technologies and a consultant for Lung Bioengineering.
Don't underestimate the importance SQI plays in providing the personalized component. Better evaluation equates to higher quality and more frequent transplants.
Be the first to comment on this post